Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

Research output: Contribution to journalReviewResearchpeer-review

  1. The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcriptome profiling of mice testes following low dose irradiation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Umbilical cord blood-derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Parental Acceptance Rate of Testicular Tissue Cryopreservation in Danish Boys with Cryptorchidism

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Biological and Clinical Rationale for Androgen Priming in Ovarian Stimulation

    Research output: Contribution to journalReviewResearchpeer-review

  • Carlo Alviggi
  • Sandro C Esteves
  • Raoul Orvieto
  • Alessandro Conforti
  • Antonio La Marca
  • Robert Fischer
  • Claus Y Andersen
  • Klaus Bühler
  • Sesh K Sunkara
  • Nikolaos P Polyzos
  • Ida Strina
  • Luigi Carbone
  • Fabiola C Bento
  • Daniela Galliano
  • Hakan Yarali
  • Lan N Vuong
  • Michael Grynberg
  • Panagiotis Drakopoulos
  • Pedro Xavier
  • Joaquin Llacer
  • Fernando Neuspiller
  • Marcos Horton
  • Matheus Roque
  • Evangelos Papanikolaou
  • Manish Banker
  • Michael H Dahan
  • Shu Foong
  • Herman Tournaye
  • Christophe Blockeel
  • Alberto Vaiarelli
  • Peter Humaidan
  • Filippo M Ubaldi
  • POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group
View graph of relations

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.

Original languageEnglish
JournalReproductive Biology and Endocrinology
Issue number1
Pages (from-to)45
Publication statusPublished - 13 May 2020

Bibliographical note

Publisher Copyright:
© 2020 The Author(s).

Copyright 2020 Elsevier B.V., All rights reserved.

    Research areas

  • Betacoronavirus, Coronavirus, Coronavirus Infections, Female, Fertilization in Vitro, Humans, Infertility, Female/therapy, Pandemics, Pneumonia, Viral, Pregnancy, Reproductive Health Services/organization & administration, Reproductive Techniques, Assisted, Sperm Injections, Intracytoplasmic, In vitro fertilization, Intracytoplasmic sperm injection, Assisted reproductive technology, COVID-19, Poseidon criteria, Infertility, Viewpoint

ID: 61254126